| Literature DB >> 23112741 |
Richard E Connon1, Juergen Geist, Inge Werner.
Abstract
Ecotoxicology faces the challenge of assessing and predicting the effects of an increasing number of chemical stressors on aquatic species and ecosystems. Herein we review currently applied tools in ecological risk assessment, combining information on exposure with expected biological effects or environmental water quality standards; currently applied effect-based tools are presented based on whether exposure occurs in a controlled laboratory environment or in the field. With increasing ecological relevance the reproducibility, specificity and thus suitability for standardisation of methods tends to diminish. We discuss the use of biomarkers in ecotoxicology including ecotoxicogenomics-based endpoints, which are becoming increasingly important for the detection of sublethal effects. Carefully selected sets of biomarkers allow an assessment of exposure to and effects of toxic chemicals, as well as the health status of organisms and, when combined with chemical analysis, identification of toxicant(s). The promising concept of "adverse outcome pathways (AOP)" links mechanistic responses on the cellular level with whole organism, population, community and potentially ecosystem effects and services. For most toxic mechanisms, however, practical application of AOPs will require more information and the identification of key links between responses, as well as key indicators, at different levels of biological organization, ecosystem functioning and ecosystem services.Entities:
Keywords: adverse outcome pathways, systems biology; aquatic toxicology; bioassays; biomarkers; ecological monitoring; ecosystem effects; ecotoxicogenomics; ecotoxicology; toxicity identification
Mesh:
Year: 2012 PMID: 23112741 PMCID: PMC3478868 DOI: 10.3390/s120912741
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1.Different types of response to toxicant exposure: (a) classical dose-response (greater effect with increasing dose) and (b) example of a nonmonotonic response (greater effect with decreasing dose after peak, referring to sublethal effects).
Assessment or safety factors for the derivation of environmental quality standards from toxicity data [12].
| At least one short-term LC50/EC50 from each of three trophic levels (fish, invertebrates (preferred | 1,000 |
| One long-term EC10 or NOEC (either fish or | 100 |
| Two long-term results from (e.g., EC10 or NOECs) from species representing two trophic levels (Fish and/or | 50 |
| Long-term results (e.g., EC10 or NOECs) from at least three species (normally fish, | 10 |
| Species sensitivity distribution (SSD) method | 5-1 (to be justified case-by-case) |
| Field data or model ecosystem | Reviewed on a case-by-case basis |
Figure 2.Determination of toxicity-exposure ratios (TER) or risk quotients by combining data on exposure scenarios with expected biological effects and/or environmental standards.
Figure 3.Two approaches to mixture toxicity assessment: effect prediction using mathematical modeling and single–substance toxicity data, and effect measurement using effect-based biological tests.
Figure 4.Different biological approaches exist for measuring toxicity of chemicals and their effects in the aquatic environment. With increasing ecological relevance the reproducibility, specificity and thus suitability for standardization of methods diminishes. Biomarkers can help bridge this gap as they can be effect- and/or chemical specific.
Examples of promising effect-based in vitro tests and chemicals they respond to (ISO: International Organization for Standardization; DIN: Deutsches Institut für Normung; German Institute for Standardization).
| Aryl hydrocarbon (Ah) receptor (in-) activation | Recombinant cell based assays, e.g., H4IIE-luc, AhR-CAFLUX, DR-CALUX® | Dioxins, coplanar polychlorinated biphenyls (PCBs), poly-aromatic hydrocarbons (PAHs) | [ |
| [ | |||
| [ | |||
| (Anti-) Estrogenicity | (anti-) Yeast estrogen screen (YES) | Natural and synthetic estrogens, bisphenol A, nonylphenol, phthalates (anti), and others. | [ |
| Cell-based reporter gene assays, such as T47D. Luc, T47D-KBluc, ER CALUX® | [ | ||
| [ | |||
| [ | |||
| Cell proliferation assay (MCF-7, E-screen) | [ | ||
| (Anti-) Androgenicity | (anti-) yeast androgen screen (YAS) | Natural and synthetic androgens, e.g., androstanedione | [ |
| Cell-based reporter gene assays, such as AR-CALUX® | [ | ||
| Thyroid hormone disruption | Transthyretin (TTR)-binding assay | Polybrominated diphenyl ethers (PBDEs), PCBs, and other halogenated phenols, pesticides | [ |
| Cell-based reporter gene assays, such as TR CALUX® | [ | ||
| Cell proliferation assay (T-Screen) | [ | ||
| Genotoxicity/DNA damage | Ames assay | Heavy metals, pesticides, PAHs and others | ISO 16240, 2005, DIN 38415-3, 1999 |
| UmuC-assay | ISO13829, 2000 | ||
| Micronucleus assay | ISO 21427-2, 2006 | ||
| Neurotoxicity | Inhibition of acetylcholinesterase | Organophosphate/carbamate insecticides | DIN 38415-1 |
| [ | |||
| Inhibition of Photosynthesis | Combined algae test | Herbicides | [ |
| Cytotoxicity | Microtox (luminescent bacteria) assay | Unspecific | ISO 11348-3 |
| [ | |||
| Cell viability assays such as MTT or neutral red staining | Unspecific | [ | |
| [ |
Species, exposure periods, test types and endpoints used for some standardized in vivo bioassays in freshwater.
| 72–96 h | chronic | growth | ISO 8692, [ | |
| 48 h | acute | mortality | ISO 6341-L40, | |
| 21 days | chronic | fecundity | US EPA, 2002 | |
| 96 h | acute | mortality | ISO 20665, [ | |
| 7–8 days | chronic | fecundity | ||
| 96 h | acute | mortality | ISO 7346 | |
| 28 days | chronic | growth | ISO 10229 | |
| 96 h | acute | mortality | [ | |
| 7 days | chronic | growth |
Examples of promising biomarkers used to assess exposure to chemicals, and health status of wild fish in environmental monitoring.
| Ah receptor | CYP1A (mRNA, protein) | [ |
| (in-) activation | EROD-Assay | ISO/TS 23893-2 |
| Metal sequestration | Metallothionein (protein) | [ |
| Endocrine disruption | Vitellogenin, protein | ISO/DIS 23893-3 |
| Vitellogenin, mRNA | (under development), [ | |
| CYP19/aromatase (mRNA, protein, activity) | [ | |
| Steroid levels (blood) | [ | |
| Histopathological changes in gonadal tissue | [ | |
| Thyroid hormone disruption | Transthyretin (TTR), mRNA | [ |
| Thyroid hormone levels | ||
| Genotoxic effects | Micronucleus test | ISO 12427-2 |
| DNA adducts | [ | |
| DNA strand breaks (Comet assay) | [ | |
| Oxidative stress | Lipid peroxidation | [ |
| Phase II enzymes and cofactors | [ | |
| Antioxidant enzymes | ||
| Neurotoxicity | Inhibition of acetylcholinesterase activity | [ |
| Immunotoxicity | Phagocytic activity | [ |
| Macrophage aggregates | [ | |
| Other blood parameters | [ | |
| Cellular integrity | Neutral red retention assay (lysosomal stability assay) | [ |
| Cell/Tissue damage | Histopathological changes | [ |
Figure 5.A suite of assessment types may be used to investigate links or associations across different levels of biological organization, as well as the interactions amongst networks in response to perturbations within a biological system.